Si-Ping Han

Si-ping Han is a highly accomplished professional with a strong background in material science and physics. Currently serving as Co-founder and CEO of NewCo since January 2024, Si-ping is also a Co-founder and Chief Technology Officer at Switch Therapeutics since July 2020. Prior experience includes roles as a Postdoctoral Fellow and Visiting Postdoc at City of Hope from 2010 to July 2020, and a Postdoctoral Scholar at the California Institute of Technology from September 2010 to July 2020. Si-ping earned a PhD in Material Science and a Bachelor’s Degree in Physics from Caltech, where education was completed from 2004 to 2010.